MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Anatomy-guided injections of Botulinum neurotoxin in neck muscles: how accurate is needle placement?

    A. Kreisler, C. Simonin, A. Degardin, E. Mutez, L. Defebvre (Lille, France)

    Objective: To assess the accuracy of anatomy-guided BoNT injections in cervical muscles. Background: Botulinum neurotoxin (BoNT) is the first line therapy for cervical dystonia; some…
  • MDS Virtual Congress 2020

    Recent Clinical variation of Segawa Disease in Japan

    K. Hoshino, K. Kimura, Y. Nagao, M. Fukumizu, H. Fukutda, M. Nozaki, M. Hayashi, I. Kawahata (Tokyo, Japan)

    Objective: To analyze clinical phenotype of recent variation of Segawa disease(GCHⅠ deficiency, DYT5a)in Japan. Background: Segawa Disease(SD)is  major  dystonia in children found by Prof.Masaya Segawa…
  • MDS Virtual Congress 2020

    Case of percussionist dystonia in playing the janggu, a traditional Korean percussive instrument

    S.K Song, J.H Kang (Jejusi, Republic of Korea)

    Objective: To describe a case of task-specific dystonia. Background: Musician’s dystonia(MD) is a type of task-specific dystonia that occurs during playing musical instruments. MD may…
  • MDS Virtual Congress 2020

    Idiopathic cervical dystonia – does autoimmunity play a hand?

    A. Panwar, N. Sawal, D. Garg, R. Kaur (Chandigarh, India)

    Objective: To evaluate efficacy of immunosuppression using glucocorticoids in 2 patients of recently diagnosed cervical dystonia(CD). Background: Most cases of CD are idiopathic. Most effective…
  • MDS Virtual Congress 2020

    Implementation of an online, interactive curriculum in movement disorders at nine neurology residency programs

    S. Schaefer, Z. London, J. Ferrara, M. McCoyd, C. Cronin, E. Poole Pharr, R. Price, M. Cincotta, H. Rigby, S. Vota, M. Slade, J. Moeller (New Haven, CT, USA)

    Objective: Determine knowledge growth and resident satisfaction with an online curriculum in movement disorders across multiple programs. Background: Exposure to movement disorders in residency is…
  • MDS Virtual Congress 2020

    Study on the clinical features of Parkinson’s disease with probable rapid eye movement sleep behavior disorder

    J. Liu, Y. Xiang, C. Wan, X. Yan, B. Tang, J. Guo (Changsha, Hunan, China)

    Objective: To investigate the clinical features and associated factors of Parkinson's disease (PD) patients with probable rapid eye movement sleep behavior disorder (PD-pRBD) Background: RBD…
  • MDS Virtual Congress 2020

    Writer’s cramp: A focal dystonia exacerbated by psychological symptoms

    A. Verghese (Georgetown, Malaysia)

    Objective: Here we retrospectively analysed nineteen patients followed up in our centre, the Neurology Unit of the Penang General Hospital, for writer’s cramp from the…
  • MDS Virtual Congress 2020

    The role of polymorphic allelic variants of the VEGFα and TGFβ gene in the development of cerebrovascular disorders in patients with metabolic syndrome

    S.h Shokhimardonov, S.h Xudjanov, F. Shermuhammedova, S.h Kuzieva (Tashkent, Uzbekistan)

    Objective: The aim of the study was to understand the link between the VEGFα and TGFβ genes in the development of stroke in patients with…
  • MDS Virtual Congress 2020

    Healthcare resource utilisation and costs among patients with versus without Huntington’s disease in the US population

    A. Exuzides, T.M To, I. Abbass, A. Surinach, R. Fuller, J. Luo (South San Francisco, CA, USA)

    Objective: Compare the marginal healthcare resource utilisation (HRU) and costs between US patients with Huntington’s disease (HD) and non-HD controls. Background: HD is a genetic,…
  • MDS Virtual Congress 2020

    A longitudinal PET study to assess the state of microglia activation in a Phase 2 study of Laquinimod as a treatment for Huntington’s disease (LEGATO-HD)

    A.A Roussakis, M. Gennaro, M.F Gordon, R. Reilmann, B. Borowsky, G. Rynkowski, J.M Savola, M.R Hayden, R. Gunn, S. Tabrizi, P. Piccini (London, United Kingdom)

    Objective: To assess in vivo in Huntington’s disease (HD) changes in microglia activation state, due to treatment with laquinimod, as reflected by changes in 11C-PBR28…
  • « Previous Page
  • 1
  • …
  • 74
  • 75
  • 76
  • 77
  • 78
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley